<em class="pub-author">EMCDDA,</em>
<em class="pub-local">Lisbon,</em>
<em class="pub-date"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2020-12-14T00:00:00+00:00">December 2020</span></em>
<div class="summary">
<h2 class="publications-summary">Summary</h2>
<div class="field field-name-field-summary field-type-text-long field-label-hidden"><div class="field-items" readability="9"><div class="field-item even" readability="13">The Evidence database is a core component of the EMCDDA’s Best Practice Portal. The portal is a resource for professionals, policymakers and researchers in the drugs field and provides information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit methodological process which is described in this document.
Protokol vir die opdatering van die Bewysdatabasis van die Beste Praktykportaal
<div class="publication-attachments pdf">
<strong>Download as PDF</strong> </div>
<div class="main-subject"><h3 class="field-label"><i class="fa fa-tag"/> Main subject: </h3><p class="field-items"><span class="field-item"><a href="/af/topic/best-practice">best practice</a></span></p></div>
VRYWARING: Inligting en menings wat in die artikels weergegee word, is dié van diegene wat dit vermeld en dit is hul eie verantwoordelikheid. Publikasie in The European Times beteken nie outomaties onderskrywing van die siening nie, maar die reg om dit uit te druk.
VRYWARINGVERTALINGS: Alle artikels op hierdie webwerf word in Engels gepubliseer. Die vertaalde weergawes word gedoen deur 'n outomatiese proses bekend as neurale vertalings. As jy twyfel, verwys altyd na die oorspronklike artikel. Dankie vir die begrip.
- Advertensie -
Meer van die skrywer
- EKSKLUSIEWE INHOUD -
- Advertensie -
